(Q30843979)
Statements
1 reference
Obinutuzumab (GA101) in relapsed/refractory chronic lymphocytic leukemia: final data from the phase 1/2 GAUGUIN study (English)
1 reference
Michael Hallek
1 reference
Sophie de Guibert
1 reference
Marie-Sarah Dilhuydy
1 reference
Franck Morschhauser
1 reference
Veronique Leblond
1 reference
Jehan Dupuis
1 reference
Beatrice Mahe
1 reference
Reda Bouabdallah
1 reference
Guiyuan Lei
1 reference
Michael Wenger
1 reference
Elisabeth Wassner-Fritsch
1 reference
20 August 2014
1 reference
Identifiers
1 reference